{"DataElement":{"publicId":"3655869","version":"1","preferredName":"Breast Cancer American Joint Committee on Cancer (AJCC) Edition 7 Pathologic Regional Lymph Node N Stage","preferredDefinition":"Extent of the regional lymph node involvement for the breast carcinoma based on evidence obtained from pathologic examination through completion of definitive surgery.","longName":"2189064v1.0:3655846v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"2189064","version":"1","preferredName":"Breast Tumor Pathologic N Stage","preferredDefinition":"Information related to pathologic N stage of a breast tumor.","longName":"BRST_TUMOR_P_N","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2206465","version":"1","preferredName":"Breast Neoplasm","preferredDefinition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12971:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-F64A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2428379","version":"1","preferredName":"Pathologic N Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"C25610:C25580","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"053C2A34-084E-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E5DFFFAB-D431-4E29-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-07","modifiedBy":"TAYLORT","dateModified":"2017-11-17","changeDescription":"11/17/17 tt associated with CS/CSI. 9/13/17 tt transferred context; changed def - 1st letter upper case; changed Reg Status to Qualified.  Updated to use Property based on NCIt concepts","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3655846","version":"1","preferredName":"Breast Cancer American Joint Committee on Cancer (AJCC) Edition 7 Pathologic N Stage","preferredDefinition":"A pathologic finding about one or more characteristics of breast cancer, following the rules of the TNM AJCC v7 classification system as they pertain to staging of regional lymph nodes.  The classification is based on axillary lymph node dissection with or without sentinel lymph node biopsy. (partially adapted from AJCC 7th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3655846v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"3","maxLength":"9","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"pN0","valueDescription":"Breast Cancer pN0 TNM Finding v7","ValueMeaning":{"publicId":"3655848","version":"1","preferredName":"Breast Cancer pN0 TNM Finding v7","longName":"3655848","preferredDefinition":"Breast cancer without histological evidence of regional lymph node involvement.  Lymph nodes containing only isolated tumor cell clusters are excluded from the total positive node count for purposes of regional lymph node classification, but should be included in the total number of nodes evaluated. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN0 TNM Finding v7","conceptCode":"C88349","definition":"Breast cancer without histological evidence of regional lymph node involvement.  Lymph nodes containing only isolated tumor cell clusters are excluded from the total positive node count for purposes of regional lymph node classification, but should be included in the total number of nodes evaluated. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4117659-9D38-8B68-E040-BB89AD435F51","latestVersionIndicator":"Yes","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"ZHANGWE","dateModified":"2021-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4117659-9D51-8B68-E040-BB89AD435F51","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"ONEDATA","dateModified":"2013-01-24","deletedIndicator":"No"},{"value":"pN0(i+)","valueDescription":"Breast Cancer pN0(i+) TNM Finding v7","ValueMeaning":{"publicId":"3655850","version":"1","preferredName":"Breast Cancer pN0(i+) TNM Finding v7","longName":"3655850","preferredDefinition":"Breast cancer with malignant cells in regional lymph node(s) no greater than 0.2 mm (detected by H&E or immunohistochemistry including isolated tumor cell clusters).  (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN0(i+) TNM Finding v7","conceptCode":"C88351","definition":"Breast cancer with malignant cells in regional lymph node(s) no greater than 0.2 mm (detected by H&E or immunohistochemistry including isolated tumor cell clusters).  (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4117659-9D5E-8B68-E040-BB89AD435F51","latestVersionIndicator":"Yes","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4117659-9D77-8B68-E040-BB89AD435F51","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"ONEDATA","dateModified":"2013-01-24","deletedIndicator":"No"},{"value":"pN0(i-)","valueDescription":"Breast Cancer pN0(i-) TNM Finding v7","ValueMeaning":{"publicId":"3655852","version":"1","preferredName":"Breast Cancer pN0(i-) TNM Finding v7","longName":"3655852","preferredDefinition":"Breast cancer without histological evidence of regional lymph node involvement, and with negative immunohistochemistry.  (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN0(i-) TNM Finding v7","conceptCode":"C88350","definition":"Breast cancer without histological evidence of regional lymph node involvement, and with negative immunohistochemistry.  (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4117659-9D84-8B68-E040-BB89AD435F51","latestVersionIndicator":"Yes","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4117659-9D9D-8B68-E040-BB89AD435F51","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"ONEDATA","dateModified":"2013-01-24","deletedIndicator":"No"},{"value":"pN0(mol+)","valueDescription":"Breast Cancer pN0(mol+) TNM Finding","ValueMeaning":{"publicId":"2924370","version":"1","preferredName":"Breast Cancer pN0(mol+) TNM Finding","longName":"2924370","preferredDefinition":"Breast cancer with positive molecular findings by RT-PCR, but without histological or immunohistochemical evidence of regional lymph node involvement. (from AJCC 6th and 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN0(mol+) TNM Finding v6 and v7","conceptCode":"C48995","definition":"Breast cancer with positive molecular findings by RT-PCR, but without histological or immunohistochemical evidence of regional lymph node involvement.  (from AJCC 6th and 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FCB3DDF-83E9-F24C-E040-BB89AD432006","latestVersionIndicator":"Yes","beginDate":"2009-07-28","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4117659-9DB1-8B68-E040-BB89AD435F51","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"ONEDATA","dateModified":"2013-01-24","deletedIndicator":"No"},{"value":"pN0(mol-)","valueDescription":"Breast Cancer pN0(mol-) TNM Finding","ValueMeaning":{"publicId":"2924372","version":"1","preferredName":"Breast Cancer pN0(mol-) TNM Finding","longName":"2924372","preferredDefinition":"Breast cancer without histological evidence of regional lymph node involvement, and with negative molecular findings by RT-PCR. (from AJCC 6th and 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN0(mol-) TNM Finding v6 and v7","conceptCode":"C48994","definition":"Breast cancer without histological evidence of regional lymph node involvement, and with negative molecular findings by RT-PCR. (from AJCC 6th and 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FCB3DDF-840F-F24C-E040-BB89AD432006","latestVersionIndicator":"Yes","beginDate":"2009-07-28","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4117659-9DC6-8B68-E040-BB89AD435F51","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"ONEDATA","dateModified":"2013-01-24","deletedIndicator":"No"},{"value":"pN1","valueDescription":"Breast Cancer pN1 TNM Finding v7","ValueMeaning":{"publicId":"3655854","version":"1","preferredName":"Breast Cancer pN1 TNM Finding v7","longName":"3655854","preferredDefinition":"Breast cancer with micrometastases; or metastases in 1 to 3 axillary lymph nodes; and/or metastases in internal mammary nodes, with the metastases detected by sentinel lymph node biopsy but not clinically detected.  \"Not clinically detected\" is defined by imaging studies (excluding lymphoscintigraphy) or by clinical examination. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN1 TNM Finding v7","conceptCode":"C88352","definition":"Breast cancer with micrometastases; or metastases in 1 to 3 axillary lymph nodes; and/or metastases in internal mammary nodes, with the metastases detected by sentinel lymph node biopsy but not clinically detected.  \"Not clinically detected\" is defined by imaging studies (excluding lymphoscintigraphy) or by clinical examination. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4117659-9DD4-8B68-E040-BB89AD435F51","latestVersionIndicator":"Yes","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"ZHANGWE","dateModified":"2021-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4117659-9DED-8B68-E040-BB89AD435F51","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"ONEDATA","dateModified":"2013-01-24","deletedIndicator":"No"},{"value":"pN1a","valueDescription":"Breast Cancer pN1a TNM Finding","ValueMeaning":{"publicId":"2924364","version":"1","preferredName":"Breast Cancer pN1a TNM Finding","longName":"2924364","preferredDefinition":"Breast cancer with metastasis in 1 to 3 axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm). (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN1a TNM Finding v6 and v7","conceptCode":"C48998","definition":"Breast cancer with metastasis in 1 to 3 axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm). (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FCB3DDF-8377-F24C-E040-BB89AD432006","latestVersionIndicator":"Yes","beginDate":"2009-07-28","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4117659-9E01-8B68-E040-BB89AD435F51","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"ONEDATA","dateModified":"2013-01-24","deletedIndicator":"No"},{"value":"pN1b","valueDescription":"Breast Cancer pN1b TNM Finding v7","ValueMeaning":{"publicId":"3655856","version":"1","preferredName":"Breast Cancer pN1b TNM Finding v7","longName":"3655856","preferredDefinition":"Breast cancer with metastases in internal mammary lymph nodes with micrometastases or macrometastases detected by sentinel lymph node biopsy but not clinically detected.  \"Not clinically detected\" is defined by imaging studies (excluding lymphoscintigraphy) or by clinical examination. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN1b TNM Finding v7","conceptCode":"C88354","definition":"Breast cancer with metastases in internal mammary lymph nodes with micrometastases or macrometastases detected by sentinel lymph node biopsy but not clinically detected.  \"Not clinically detected\" is defined by imaging studies (excluding lymphoscintigraphy) or by clinical examination. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4117659-9E0F-8B68-E040-BB89AD435F51","latestVersionIndicator":"Yes","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4117659-9E28-8B68-E040-BB89AD435F51","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"ONEDATA","dateModified":"2013-01-24","deletedIndicator":"No"},{"value":"pN1c","valueDescription":"Breast Cancer pN1c TNM Finding v7","ValueMeaning":{"publicId":"3655858","version":"1","preferredName":"Breast Cancer pN1c TNM Finding v7","longName":"3655858","preferredDefinition":"Breast cancer with metastases in 1 to 3 axillary lymph nodes and in internal mammary lymph nodes with micrometastases or macrometastases detected by sentinel lymph node biopsy but not clinically detected.  \"Not clinically detected\" is defined by imaging studies (excluding lymphoscintigraphy) or by clinical examination. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN1c TNM Finding v7","conceptCode":"C88355","definition":"Breast cancer with metastases in 1 to 3 axillary lymph nodes and in internal mammary lymph nodes with micrometastases or macrometastases detected by sentinel lymph node biopsy but not clinically detected.  \"Not clinically detected\" is defined by imaging studies (excluding lymphoscintigraphy) or by clinical examination. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4117659-9E35-8B68-E040-BB89AD435F51","latestVersionIndicator":"Yes","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4117659-9E4E-8B68-E040-BB89AD435F51","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"ONEDATA","dateModified":"2013-01-24","deletedIndicator":"No"},{"value":"pN1mi","valueDescription":"Breast Cancer pN1mi TNM Finding v7","ValueMeaning":{"publicId":"3655860","version":"1","preferredName":"Breast Cancer pN1mi TNM Finding v7","longName":"3655860","preferredDefinition":"Breast cancer with micrometastases (greater than 0.2 mm and/or more than 200 cells, but none greater than 2.0 mm) (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN1mi TNM Finding v7","conceptCode":"C88353","definition":"Breast cancer with micrometastases (greater than 0.2 mm and/or more than 200 cells, but none greater than 2.0 mm) (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4117659-9E5B-8B68-E040-BB89AD435F51","latestVersionIndicator":"Yes","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4117659-9E74-8B68-E040-BB89AD435F51","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"ONEDATA","dateModified":"2013-01-24","deletedIndicator":"No"},{"value":"pN2","valueDescription":"Breast Cancer pN2 TNM Finding v7","ValueMeaning":{"publicId":"3655862","version":"1","preferredName":"Breast Cancer pN2 TNM Finding v7","longName":"3655862","preferredDefinition":"Breast cancer with metastases in 4 to 9 axillary lymph nodes, or metastases in clinically detected internal mammary lymph nodes in the absence of axillary lymph node metastases.  \"Clinically detected\" is defined as detected by imaging studies (excluding lymphoscintigraphy) or by clinical examination and having characteristics highly suspicious for malignancy or a presumed pathologic macrometastasis based on fine needle aspiration biopsy with cytologic examination. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN2 TNM Finding v7","conceptCode":"C88358","definition":"Breast cancer with metastases in 4 to 9 axillary lymph nodes, or metastases in clinically detected internal mammary lymph nodes in the absence of axillary lymph node metastases.  \"Clinically detected\" is defined as detected by imaging studies (excluding lymphoscintigraphy) or by clinical examination and having characteristics highly suspicious for malignancy or a presumed pathologic macrometastasis based on fine needle aspiration biopsy with cytologic examination. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4117659-9E81-8B68-E040-BB89AD435F51","latestVersionIndicator":"Yes","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"ZHANGWE","dateModified":"2021-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4117659-9E9A-8B68-E040-BB89AD435F51","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"ONEDATA","dateModified":"2013-01-24","deletedIndicator":"No"},{"value":"pN2a","valueDescription":"Breast Cancer pN2a TNM Finding","ValueMeaning":{"publicId":"2924699","version":"1","preferredName":"Breast Cancer pN2a TNM Finding","longName":"2924699","preferredDefinition":"Breast cancer with metastasis in 4 to 9 axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm). (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN2a TNM Finding v6 and v7","conceptCode":"C49002","definition":"Breast cancer with metastasis in 4 to 9 axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm). (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FCB1360-FE58-8A77-E040-BB89AD431272","latestVersionIndicator":"Yes","beginDate":"2009-07-28","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4117659-9EAE-8B68-E040-BB89AD435F51","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"ONEDATA","dateModified":"2013-01-24","deletedIndicator":"No"},{"value":"pN2b","valueDescription":"Breast Cancer pN2b TNM Finding v7","ValueMeaning":{"publicId":"3655864","version":"1","preferredName":"Breast Cancer pN2b TNM Finding v7","longName":"3655864","preferredDefinition":"Breast cancer with metastases in clinically detected internal mammary lymph nodes in the absence of axillary lymph node metastases.  \"Clinically detected\" is defined as detected by imaging studies (excluding lymphoscintigraphy) or by clinical examination and having characteristics highly suspicious for malignancy or a presumed pathologic macrometastasis based on fine needle aspiration biopsy with cytologic examination. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN2b TNM Finding v7","conceptCode":"C88360","definition":"Breast cancer with metastases in clinically detected internal mammary lymph nodes in the absence of axillary lymph node metastases.  \"Clinically detected\" is defined as detected by imaging studies (excluding lymphoscintigraphy) or by clinical examination and having characteristics highly suspicious for malignancy or a presumed pathologic macrometastasis based on fine needle aspiration biopsy with cytologic examination. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4117659-9EBC-8B68-E040-BB89AD435F51","latestVersionIndicator":"Yes","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4117659-9ED5-8B68-E040-BB89AD435F51","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"ONEDATA","dateModified":"2013-01-24","deletedIndicator":"No"},{"value":"pN3","valueDescription":"Breast Cancer pN3 TNM Finding v7","ValueMeaning":{"publicId":"3655866","version":"1","preferredName":"Breast Cancer pN3 TNM Finding v7","longName":"3655866","preferredDefinition":"Breast cancer with metastases in 10 or more axillary lymph nodes; or in infraclavicular (level III axillary) lymph nodes; or in clinically detected ipsilateral internal mammary lymph nodes in the presence of 1 or more positive level I, II axillary lymph nodes; or in more than 3 axillary lymph nodes and in internal mammary lymph nodes with micrometastases or macrometastases detected by sentinel lymph node biopsy but not clinically detected; or in ipsilateral supraclavicular lymph nodes. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN3 TNM Finding v7","conceptCode":"C88361","definition":"Breast cancer with metastases in 10 or more axillary lymph nodes; or in infraclavicular (level III axillary) lymph nodes; or in clinically detected ipsilateral internal mammary lymph nodes in the presence of 1 or more positive level I, II axillary lymph nodes; or in more than 3 axillary lymph nodes and in internal mammary lymph nodes with micrometastases or macrometastases detected by sentinel lymph node biopsy but not clinically detected; or in ipsilateral supraclavicular lymph nodes. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4117659-9EE2-8B68-E040-BB89AD435F51","latestVersionIndicator":"Yes","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"ZHANGWE","dateModified":"2021-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4117659-9EFB-8B68-E040-BB89AD435F51","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"ONEDATA","dateModified":"2013-01-24","deletedIndicator":"No"},{"value":"pN3a","valueDescription":"Breast Cancer pN3a TNM Finding","ValueMeaning":{"publicId":"2924695","version":"1","preferredName":"Breast Cancer pN3a TNM Finding","longName":"2924695","preferredDefinition":"Breast cancer with metastases in 10 or more axillary lymph nodes (at least one tumor deposit greater than 2.0 mm); or metastases to the infraclavicular (level III axillary) lymph nodes. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN3a TNM Finding v6 and v7","conceptCode":"C49005","definition":"Breast cancer with metastases in 10 or more axillary lymph nodes (at least one tumor deposit greater than 2.0 mm); or metastases to the infraclavicular (level III axillary) lymph nodes. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FCB1360-FE0C-8A77-E040-BB89AD431272","latestVersionIndicator":"Yes","beginDate":"2009-07-28","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4117659-9F0F-8B68-E040-BB89AD435F51","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"ONEDATA","dateModified":"2013-01-24","deletedIndicator":"No"},{"value":"pN3b","valueDescription":"Breast Cancer pN3b TNM Finding v7","ValueMeaning":{"publicId":"3655868","version":"1","preferredName":"Breast Cancer pN3b TNM Finding v7","longName":"3655868","preferredDefinition":"Breast cancer with metastases in clinically detected ipsilateral internal mammary lymph nodes in the presence of 1 or more positive axillary lymph nodes; or in more than 3 axillary lymph nodes and in internal mammary lymph nodes with micrometastases or macrometastases detected by sentinel lymph node biopsy but not clinically detected. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN3b TNM Finding v7","conceptCode":"C88362","definition":"Breast cancer with metastases in clinically detected ipsilateral internal mammary lymph nodes in the presence of 1 or more positive axillary lymph nodes; or in more than 3 axillary lymph nodes and in internal mammary lymph nodes with micrometastases or macrometastases detected by sentinel lymph node biopsy but not clinically detected. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4117659-9F1D-8B68-E040-BB89AD435F51","latestVersionIndicator":"Yes","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4117659-9F36-8B68-E040-BB89AD435F51","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"ONEDATA","dateModified":"2013-01-24","deletedIndicator":"No"},{"value":"pN3c","valueDescription":"Breast Cancer pN3c TNM Finding","ValueMeaning":{"publicId":"2924691","version":"1","preferredName":"Breast Cancer pN3c TNM Finding","longName":"2924691","preferredDefinition":"Breast cancer with metastasis in ipsilateral supraclavicular lymph nodes. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN3c TNM Finding v6 and v7","conceptCode":"C49007","definition":"Breast cancer with metastasis in ipsilateral supraclavicular lymph nodes. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FCB1360-FDC0-8A77-E040-BB89AD431272","latestVersionIndicator":"Yes","beginDate":"2009-07-28","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4117659-9F4A-8B68-E040-BB89AD435F51","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"ONEDATA","dateModified":"2013-01-24","deletedIndicator":"No"},{"value":"pNX","valueDescription":"Breast Cancer pNX TNM Finding","ValueMeaning":{"publicId":"2924343","version":"1","preferredName":"Breast Cancer pNX TNM Finding","longName":"2924343","preferredDefinition":"Breast cancer in which regional lymph nodes cannot be assessed (e.g., previously removed, or not removed for pathologic study). (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pNX TNM Finding v6 and v7","conceptCode":"C48990","definition":"Breast cancer in which regional lymph nodes cannot be assessed (e.g., previously removed, or not removed for pathologic study). (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FCB3DDF-819F-F24C-E040-BB89AD432006","latestVersionIndicator":"Yes","beginDate":"2009-07-28","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-07-28","modifiedBy":"ZHANGWE","dateModified":"2021-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4117659-9F5F-8B68-E040-BB89AD435F51","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"ONEDATA","dateModified":"2013-01-24","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3655845","version":"1","preferredName":"Breast Cancer Pathologic Regional Lymph Nodes TNM Finding v7 American Joint Committee on Cancer Stage","preferredDefinition":"A pathologic finding about one or more characteristics of breast cancer, following the rules of the TNM AJCC v7 classification system as they pertain to staging of regional lymph nodes.  The classification is based on axillary lymph node dissection with or without sentinel lymph node biopsy. (partially adapted from AJCC 7th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C88348:C39315:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer Pathologic Regional Lymph Nodes TNM Finding v7","conceptCode":"C88348","definition":"A pathologic finding about one or more characteristics of breast cancer, following the rules of the TNM AJCC v7 classification system as they pertain to staging of regional lymph nodes.  The classification is based on axillary lymph node dissection with or without sentinel lymph node biopsy. (partially adapted from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4117659-9D0C-8B68-E040-BB89AD435F51","latestVersionIndicator":"Yes","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"ONEDATA","dateModified":"2013-01-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4117659-9D1D-8B68-E040-BB89AD435F51","latestVersionIndicator":"Yes","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"ZHANGWE","dateModified":"2022-03-14","changeDescription":"Created to include Pathologic specific PVs. mc 1/24/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2812571","version":"1","longName":"Lombardi Cancer Center","context":"NCIP"}]},{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"10000007","version":"1","longName":"Breast","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"5441476","version":"1","longName":"MDA2014-04-02","context":"DCP"},{"publicId":"5598962","version":"1","longName":"MDA2014-04-01","context":"DCP"}]},{"publicId":"5506112","version":"1","longName":"Breast","context":"MCL","ClassificationSchemeItems":[{"publicId":"7035094","version":"1","longName":"Breast PCA Pilot","context":"MCL"},{"publicId":"6643181","version":"1","longName":"Initial Diagnosis","context":"MCL"}]},{"publicId":"5506116","version":"1","longName":"Pathology","context":"MCL","ClassificationSchemeItems":[{"publicId":"5855640","version":"1","longName":"Breast Pathology","context":"MCL"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"10000008","version":"1","longName":"Breast","context":"NCI Standards"}]},{"publicId":"6437797","version":"1","longName":"Pre-Cancer Atlas Pilot","context":"MCL","ClassificationSchemeItems":[{"publicId":"7001791","version":"1","longName":"Breast PCA Pilot","context":"MCL"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"},{"name":"2189064v1.0:3655846v1.0","type":"USED_BY","context":"Alliance"},{"name":"BR_AJCC_PATH_N_STG","type":"C3D Name","context":"LCC"},{"name":"DCP","type":"USED_BY","context":"DCP"},{"name":"2189064v1.0:3655846v1.0","type":"USED_BY","context":"CCTG"},{"name":"CCTG","type":"USED_BY","context":"CCTG"},{"name":"BRST_AJC7_PTH_N_STG","type":"OID, CCTG","context":"CCTG"},{"name":"MCL","type":"USED_BY","context":"MCL"},{"name":"BRST_AJCC7_PATH_N_STG","type":"DCP Alt Name","context":"DCP"},{"name":"pathologic_N_stage_7","type":"MCL Alt Name","context":"MCL"}],"ReferenceDocuments":[{"name":"Pathologic N Stage","type":"Preferred Question Text","description":"Pathologic N Stage","url":null,"context":"NCI Standards"},{"name":"DCP Question Text","type":"Alternate Question Text","description":"N Stage","url":null,"context":"DCP"},{"name":"MCL-PCA","type":"Alternate Question Text","description":"Pathologic N Stage","url":null,"context":"MCL"},{"name":"DCP-Text-1","type":"Alternate Question Text","description":"Node Stage","url":null,"context":"DCP"},{"name":"MCL-Template Name","type":"Data Collection Template","description":"breast_v1-2_08sep2020.xlsx","url":"https://mcl.nci.nih.gov/resources/standards/mcl-cdes","context":"MCL"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"D4117659-9F82-8B68-E040-BB89AD435F51","latestVersionIndicator":"Yes","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"TITARENI","dateModified":"2022-01-26","changeDescription":"11/22/21 mr Added MCL PCA Breast CSI, added alt name, alt def, ref doc, per DCT. 4/17/20 jk added MCL Breast Core CSI.  Created new CDE to capture Pathologic N Stage specific PVs in new VD. mc 1/24/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}